nodes	percent_of_prediction	percent_of_DWPC	metapath
Etonogestrel—CYP3A4—Thiotepa—sarcoma	0.117	0.458	CbGbCtD
Etonogestrel—CYP3A4—Mitoxantrone—sarcoma	0.0503	0.197	CbGbCtD
Etonogestrel—CYP3A4—Vincristine—sarcoma	0.0346	0.136	CbGbCtD
Etonogestrel—CYP3A4—Etoposide—sarcoma	0.0317	0.124	CbGbCtD
Etonogestrel—CYP3A4—Doxorubicin—sarcoma	0.0216	0.0847	CbGbCtD
Etonogestrel—SHBG—hindlimb—sarcoma	0.0208	0.146	CbGeAlD
Etonogestrel—ESR1—periosteum—sarcoma	0.0206	0.144	CbGeAlD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—PLCG1—sarcoma	0.012	0.0926	CbGpPWpGaD
Etonogestrel—PGR—Ovarian Infertility Genes—GJA4—sarcoma	0.00924	0.0714	CbGpPWpGaD
Etonogestrel—PGR—mammary gland—sarcoma	0.00782	0.0549	CbGeAlD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—CREB1—sarcoma	0.00617	0.0477	CbGpPWpGaD
Etonogestrel—ESR1—mammary gland—sarcoma	0.00612	0.0429	CbGeAlD
Etonogestrel—PGR—myometrium—sarcoma	0.00555	0.039	CbGeAlD
Etonogestrel—SHBG—hematopoietic system—sarcoma	0.00529	0.0371	CbGeAlD
Etonogestrel—SHBG—connective tissue—sarcoma	0.00509	0.0357	CbGeAlD
Etonogestrel—PGR—hematopoietic system—sarcoma	0.00476	0.0334	CbGeAlD
Etonogestrel—PGR—connective tissue—sarcoma	0.00459	0.0322	CbGeAlD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00458	0.0354	CbGpPWpGaD
Etonogestrel—ESR1—myometrium—sarcoma	0.00434	0.0305	CbGeAlD
Etonogestrel—PGR—smooth muscle tissue—sarcoma	0.0042	0.0295	CbGeAlD
Etonogestrel—ESR1—embryo—sarcoma	0.00417	0.0293	CbGeAlD
Etonogestrel—SHBG—uterus—sarcoma	0.00399	0.028	CbGeAlD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—SRC—sarcoma	0.00398	0.0308	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—EZR—sarcoma	0.00382	0.0295	CbGpPWpGaD
Etonogestrel—ESR1—hematopoietic system—sarcoma	0.00373	0.0262	CbGeAlD
Etonogestrel—ESR1—FOXA1 transcription factor network—COL18A1—sarcoma	0.00363	0.028	CbGpPWpGaD
Etonogestrel—PGR—uterus—sarcoma	0.0036	0.0253	CbGeAlD
Etonogestrel—ESR1—connective tissue—sarcoma	0.00359	0.0252	CbGeAlD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—MITF—sarcoma	0.00341	0.0263	CbGpPWpGaD
Etonogestrel—SHBG—bone marrow—sarcoma	0.00339	0.0238	CbGeAlD
Etonogestrel—PGR—lymphoid tissue—sarcoma	0.00335	0.0235	CbGeAlD
Etonogestrel—ESR1—smooth muscle tissue—sarcoma	0.00328	0.023	CbGeAlD
Etonogestrel—SHBG—testis—sarcoma	0.0029	0.0203	CbGeAlD
Etonogestrel—ESR1—uterus—sarcoma	0.00281	0.0198	CbGeAlD
Etonogestrel—SHBG—Nongenotropic Androgen signaling—HRAS—sarcoma	0.0028	0.0216	CbGpPWpGaD
Etonogestrel—SHBG—liver—sarcoma	0.00274	0.0192	CbGeAlD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—COL18A1—sarcoma	0.00269	0.0208	CbGpPWpGaD
Etonogestrel—ESR1—lymphoid tissue—sarcoma	0.00262	0.0184	CbGeAlD
Etonogestrel—PGR—testis—sarcoma	0.00261	0.0183	CbGeAlD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—ATF1—sarcoma	0.00247	0.019	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen Receptor Pathway—JUN—sarcoma	0.00212	0.0164	CbGpPWpGaD
Etonogestrel—CYP3A4—hematopoietic system—sarcoma	0.00208	0.0146	CbGeAlD
Etonogestrel—ESR1—testis—sarcoma	0.00204	0.0143	CbGeAlD
Etonogestrel—ESR1—Regulation of Telomerase—WT1—sarcoma	0.002	0.0155	CbGpPWpGaD
Etonogestrel—ESR1—liver—sarcoma	0.00193	0.0136	CbGeAlD
Etonogestrel—PGR—lymph node—sarcoma	0.00189	0.0133	CbGeAlD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYOD1—sarcoma	0.00187	0.0145	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen signaling pathway—CREB1—sarcoma	0.00187	0.0144	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—sarcoma	0.0017	0.0132	CbGpPWpGaD
Etonogestrel—ESR1—lymph node—sarcoma	0.00148	0.0104	CbGeAlD
Etonogestrel—ESR1—Leptin signaling pathway—PLCG1—sarcoma	0.00141	0.0109	CbGpPWpGaD
Etonogestrel—ESR1—Estrogen signaling pathway—JUN—sarcoma	0.00134	0.0104	CbGpPWpGaD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	0.00134	0.0103	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—PDGFRA—sarcoma	0.00119	0.00921	CbGpPWpGaD
Etonogestrel—ESR1—LKB1 signaling events—CREB1—sarcoma	0.00113	0.00875	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—MMP2—sarcoma	0.0011	0.00846	CbGpPWpGaD
Etonogestrel—CYP3A4—liver—sarcoma	0.00108	0.00756	CbGeAlD
Etonogestrel—ESR1—FOXM1 transcription factor network—MMP2—sarcoma	0.00107	0.0083	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.00101	0.00782	CbGpPWpGaD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.00101	0.0078	CbGpPWpGaD
Etonogestrel—ESR1—Leptin signaling pathway—FOXO1—sarcoma	0.001	0.00773	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—FOXO1—sarcoma	0.000969	0.00749	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—PDGFRB—sarcoma	0.000967	0.00747	CbGpPWpGaD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	0.000961	0.00742	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—PDGFRA—sarcoma	0.000952	0.00736	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—FOXO1—sarcoma	0.000941	0.00727	CbGpPWpGaD
Etonogestrel—Urticaria—Thiotepa—sarcoma	0.00093	0.00197	CcSEcCtD
Etonogestrel—Malaise—Etoposide—sarcoma	0.000929	0.00196	CcSEcCtD
Etonogestrel—Abdominal pain—Thiotepa—sarcoma	0.000926	0.00196	CcSEcCtD
Etonogestrel—Body temperature increased—Thiotepa—sarcoma	0.000926	0.00196	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000921	0.00195	CcSEcCtD
Etonogestrel—Abdominal pain—Dactinomycin—sarcoma	0.000919	0.00194	CcSEcCtD
Etonogestrel—Body temperature increased—Dactinomycin—sarcoma	0.000919	0.00194	CcSEcCtD
Etonogestrel—Mood swings—Epirubicin—sarcoma	0.000909	0.00192	CcSEcCtD
Etonogestrel—Paraesthesia—Mitoxantrone—sarcoma	0.000908	0.00192	CcSEcCtD
Etonogestrel—Decreased appetite—Vincristine—sarcoma	0.000902	0.00191	CcSEcCtD
Etonogestrel—Cough—Etoposide—sarcoma	0.000899	0.0019	CcSEcCtD
Etonogestrel—Somnolence—Mitoxantrone—sarcoma	0.000899	0.0019	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Vincristine—sarcoma	0.000896	0.0019	CcSEcCtD
Etonogestrel—Fatigue—Vincristine—sarcoma	0.000895	0.00189	CcSEcCtD
Etonogestrel—Convulsion—Etoposide—sarcoma	0.000893	0.00189	CcSEcCtD
Etonogestrel—Dyspepsia—Mitoxantrone—sarcoma	0.00089	0.00188	CcSEcCtD
Etonogestrel—Hypertension—Etoposide—sarcoma	0.00089	0.00188	CcSEcCtD
Etonogestrel—Constipation—Vincristine—sarcoma	0.000888	0.00188	CcSEcCtD
Etonogestrel—Pain—Vincristine—sarcoma	0.000888	0.00188	CcSEcCtD
Etonogestrel—Pain in extremity—Doxorubicin—sarcoma	0.000888	0.00188	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—CREB1—sarcoma	0.00088	0.00679	CbGpPWpGaD
Etonogestrel—Decreased appetite—Mitoxantrone—sarcoma	0.000879	0.00186	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	0.000877	0.00678	CbGpPWpGaD
Etonogestrel—Migraine—Doxorubicin—sarcoma	0.000874	0.00185	CcSEcCtD
Etonogestrel—Affect lability—Doxorubicin—sarcoma	0.000874	0.00185	CcSEcCtD
Etonogestrel—Fatigue—Mitoxantrone—sarcoma	0.000872	0.00184	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000871	0.00184	CcSEcCtD
Etonogestrel—Discomfort—Etoposide—sarcoma	0.000867	0.00183	CcSEcCtD
Etonogestrel—Breast disorder—Epirubicin—sarcoma	0.000867	0.00183	CcSEcCtD
Etonogestrel—Constipation—Mitoxantrone—sarcoma	0.000865	0.00183	CcSEcCtD
Etonogestrel—Pain—Mitoxantrone—sarcoma	0.000865	0.00183	CcSEcCtD
Etonogestrel—Hypersensitivity—Thiotepa—sarcoma	0.000863	0.00182	CcSEcCtD
Etonogestrel—Hypersensitivity—Dactinomycin—sarcoma	0.000856	0.00181	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Vincristine—sarcoma	0.000849	0.0018	CcSEcCtD
Etonogestrel—Gastritis—Epirubicin—sarcoma	0.000849	0.00179	CcSEcCtD
Etonogestrel—Anaphylactic shock—Etoposide—sarcoma	0.000841	0.00178	CcSEcCtD
Etonogestrel—Mood swings—Doxorubicin—sarcoma	0.000841	0.00178	CcSEcCtD
Etonogestrel—Asthenia—Thiotepa—sarcoma	0.00084	0.00178	CcSEcCtD
Etonogestrel—Infection—Etoposide—sarcoma	0.000836	0.00177	CcSEcCtD
Etonogestrel—Abdominal distension—Epirubicin—sarcoma	0.000835	0.00176	CcSEcCtD
Etonogestrel—Asthenia—Dactinomycin—sarcoma	0.000834	0.00176	CcSEcCtD
Etonogestrel—Feeling abnormal—Mitoxantrone—sarcoma	0.000833	0.00176	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—CCND1—sarcoma	0.000832	0.00643	CbGpPWpGaD
Etonogestrel—Asthma—Epirubicin—sarcoma	0.000829	0.00175	CcSEcCtD
Etonogestrel—Pruritus—Thiotepa—sarcoma	0.000828	0.00175	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000827	0.00175	CcSEcCtD
Etonogestrel—Abdominal pain—Vincristine—sarcoma	0.000821	0.00174	CcSEcCtD
Etonogestrel—Body temperature increased—Vincristine—sarcoma	0.000821	0.00174	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—MMP2—sarcoma	0.000819	0.00632	CbGpPWpGaD
Etonogestrel—Skin disorder—Etoposide—sarcoma	0.000817	0.00173	CcSEcCtD
Etonogestrel—PGR—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000812	0.00627	CbGpPWpGaD
Etonogestrel—Urticaria—Mitoxantrone—sarcoma	0.000803	0.0017	CcSEcCtD
Etonogestrel—Breast disorder—Doxorubicin—sarcoma	0.000802	0.0017	CcSEcCtD
Etonogestrel—Anorexia—Etoposide—sarcoma	0.000802	0.0017	CcSEcCtD
Etonogestrel—Diarrhoea—Thiotepa—sarcoma	0.000801	0.00169	CcSEcCtD
Etonogestrel—ESR1—FOXA1 transcription factor network—JUN—sarcoma	0.0008	0.00618	CbGpPWpGaD
Etonogestrel—Body temperature increased—Mitoxantrone—sarcoma	0.000799	0.00169	CcSEcCtD
Etonogestrel—Abdominal pain—Mitoxantrone—sarcoma	0.000799	0.00169	CcSEcCtD
Etonogestrel—Bronchitis—Epirubicin—sarcoma	0.000797	0.00169	CcSEcCtD
Etonogestrel—Diarrhoea—Dactinomycin—sarcoma	0.000795	0.00168	CcSEcCtD
Etonogestrel—Gastritis—Doxorubicin—sarcoma	0.000785	0.00166	CcSEcCtD
Etonogestrel—Dysuria—Epirubicin—sarcoma	0.000775	0.00164	CcSEcCtD
Etonogestrel—Dizziness—Thiotepa—sarcoma	0.000774	0.00164	CcSEcCtD
Etonogestrel—Abdominal distension—Doxorubicin—sarcoma	0.000772	0.00163	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Epirubicin—sarcoma	0.00077	0.00163	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CREB1—sarcoma	0.000767	0.00593	CbGpPWpGaD
Etonogestrel—Asthma—Doxorubicin—sarcoma	0.000767	0.00162	CcSEcCtD
Etonogestrel—Pollakiuria—Epirubicin—sarcoma	0.000766	0.00162	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—ATF1—sarcoma	0.000766	0.00591	CbGpPWpGaD
Etonogestrel—Hypersensitivity—Vincristine—sarcoma	0.000765	0.00162	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—SRC—sarcoma	0.000759	0.00586	CbGpPWpGaD
Etonogestrel—Paraesthesia—Etoposide—sarcoma	0.000755	0.0016	CcSEcCtD
Etonogestrel—Weight increased—Epirubicin—sarcoma	0.000754	0.0016	CcSEcCtD
Etonogestrel—Weight decreased—Epirubicin—sarcoma	0.00075	0.00159	CcSEcCtD
Etonogestrel—Somnolence—Etoposide—sarcoma	0.000748	0.00158	CcSEcCtD
Etonogestrel—Hypersensitivity—Mitoxantrone—sarcoma	0.000745	0.00158	CcSEcCtD
Etonogestrel—Asthenia—Vincristine—sarcoma	0.000745	0.00157	CcSEcCtD
Etonogestrel—Vomiting—Thiotepa—sarcoma	0.000744	0.00157	CcSEcCtD
Etonogestrel—Infestation—Epirubicin—sarcoma	0.000739	0.00156	CcSEcCtD
Etonogestrel—Infestation NOS—Epirubicin—sarcoma	0.000739	0.00156	CcSEcCtD
Etonogestrel—Vomiting—Dactinomycin—sarcoma	0.000739	0.00156	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—KIT—sarcoma	0.000739	0.0057	CbGpPWpGaD
Etonogestrel—Rash—Thiotepa—sarcoma	0.000738	0.00156	CcSEcCtD
Etonogestrel—Bronchitis—Doxorubicin—sarcoma	0.000738	0.00156	CcSEcCtD
Etonogestrel—Dermatitis—Thiotepa—sarcoma	0.000738	0.00156	CcSEcCtD
Etonogestrel—Headache—Thiotepa—sarcoma	0.000733	0.00155	CcSEcCtD
Etonogestrel—Rash—Dactinomycin—sarcoma	0.000733	0.00155	CcSEcCtD
Etonogestrel—Decreased appetite—Etoposide—sarcoma	0.000731	0.00155	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—NRAS—sarcoma	0.00073	0.00564	CbGpPWpGaD
Etonogestrel—Gastrointestinal disorder—Etoposide—sarcoma	0.000726	0.00154	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—CREB1—sarcoma	0.000726	0.00561	CbGpPWpGaD
Etonogestrel—Asthenia—Mitoxantrone—sarcoma	0.000725	0.00153	CcSEcCtD
Etonogestrel—Fatigue—Etoposide—sarcoma	0.000725	0.00153	CcSEcCtD
Etonogestrel—Neuropathy peripheral—Epirubicin—sarcoma	0.000725	0.00153	CcSEcCtD
Etonogestrel—Pain—Etoposide—sarcoma	0.000719	0.00152	CcSEcCtD
Etonogestrel—Constipation—Etoposide—sarcoma	0.000719	0.00152	CcSEcCtD
Etonogestrel—Urinary tract infection—Epirubicin—sarcoma	0.000718	0.00152	CcSEcCtD
Etonogestrel—Dysuria—Doxorubicin—sarcoma	0.000717	0.00152	CcSEcCtD
Etonogestrel—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000713	0.00151	CcSEcCtD
Etonogestrel—Diarrhoea—Vincristine—sarcoma	0.00071	0.0015	CcSEcCtD
Etonogestrel—Pollakiuria—Doxorubicin—sarcoma	0.000709	0.0015	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—CREB1—sarcoma	0.000703	0.00543	CbGpPWpGaD
Etonogestrel—Weight increased—Doxorubicin—sarcoma	0.000698	0.00148	CcSEcCtD
Etonogestrel—Nausea—Thiotepa—sarcoma	0.000695	0.00147	CcSEcCtD
Etonogestrel—Weight decreased—Doxorubicin—sarcoma	0.000694	0.00147	CcSEcCtD
Etonogestrel—Sinusitis—Epirubicin—sarcoma	0.000693	0.00147	CcSEcCtD
Etonogestrel—Feeling abnormal—Etoposide—sarcoma	0.000693	0.00147	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—SRC—sarcoma	0.000692	0.00535	CbGpPWpGaD
Etonogestrel—Diarrhoea—Mitoxantrone—sarcoma	0.000692	0.00146	CcSEcCtD
Etonogestrel—Nausea—Dactinomycin—sarcoma	0.00069	0.00146	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Etoposide—sarcoma	0.000688	0.00145	CcSEcCtD
Etonogestrel—Dizziness—Vincristine—sarcoma	0.000687	0.00145	CcSEcCtD
Etonogestrel—Infestation NOS—Doxorubicin—sarcoma	0.000684	0.00145	CcSEcCtD
Etonogestrel—Infestation—Doxorubicin—sarcoma	0.000684	0.00145	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—CREB1—sarcoma	0.000683	0.00527	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	0.000674	0.00521	CbGpPWpGaD
Etonogestrel—Neuropathy peripheral—Doxorubicin—sarcoma	0.00067	0.00142	CcSEcCtD
Etonogestrel—Urticaria—Etoposide—sarcoma	0.000668	0.00141	CcSEcCtD
Etonogestrel—ESR1—FOXM1 transcription factor network—MYC—sarcoma	0.000667	0.00515	CbGpPWpGaD
Etonogestrel—Haemoglobin—Epirubicin—sarcoma	0.000667	0.00141	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—NRAS—sarcoma	0.000666	0.00515	CbGpPWpGaD
Etonogestrel—Rhinitis—Epirubicin—sarcoma	0.000665	0.00141	CcSEcCtD
Etonogestrel—Abdominal pain—Etoposide—sarcoma	0.000665	0.00141	CcSEcCtD
Etonogestrel—Body temperature increased—Etoposide—sarcoma	0.000665	0.00141	CcSEcCtD
Etonogestrel—Urinary tract infection—Doxorubicin—sarcoma	0.000665	0.00141	CcSEcCtD
Etonogestrel—Haemorrhage—Epirubicin—sarcoma	0.000664	0.0014	CcSEcCtD
Etonogestrel—Hypoaesthesia—Epirubicin—sarcoma	0.00066	0.0014	CcSEcCtD
Etonogestrel—Vomiting—Vincristine—sarcoma	0.00066	0.0014	CcSEcCtD
Etonogestrel—Pharyngitis—Epirubicin—sarcoma	0.000659	0.00139	CcSEcCtD
Etonogestrel—Urinary tract disorder—Epirubicin—sarcoma	0.000655	0.00139	CcSEcCtD
Etonogestrel—ESR1—LKB1 signaling events—MYC—sarcoma	0.000655	0.00506	CbGpPWpGaD
Etonogestrel—Rash—Vincristine—sarcoma	0.000655	0.00138	CcSEcCtD
Etonogestrel—Dermatitis—Vincristine—sarcoma	0.000654	0.00138	CcSEcCtD
Etonogestrel—Connective tissue disorder—Epirubicin—sarcoma	0.000652	0.00138	CcSEcCtD
Etonogestrel—Urethral disorder—Epirubicin—sarcoma	0.00065	0.00138	CcSEcCtD
Etonogestrel—Headache—Vincristine—sarcoma	0.00065	0.00138	CcSEcCtD
Etonogestrel—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000645	0.00498	CbGpPWpGaD
Etonogestrel—Vomiting—Mitoxantrone—sarcoma	0.000643	0.00136	CcSEcCtD
Etonogestrel—Sinusitis—Doxorubicin—sarcoma	0.000642	0.00136	CcSEcCtD
Etonogestrel—Visual impairment—Epirubicin—sarcoma	0.000639	0.00135	CcSEcCtD
Etonogestrel—Rash—Mitoxantrone—sarcoma	0.000637	0.00135	CcSEcCtD
Etonogestrel—Dermatitis—Mitoxantrone—sarcoma	0.000637	0.00135	CcSEcCtD
Etonogestrel—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	0.000634	0.0049	CbGpPWpGaD
Etonogestrel—ESR1—ATF-2 transcription factor network—CCND1—sarcoma	0.000634	0.0049	CbGpPWpGaD
Etonogestrel—Headache—Mitoxantrone—sarcoma	0.000633	0.00134	CcSEcCtD
Etonogestrel—ESR1—ATF-2 transcription factor network—JUN—sarcoma	0.000633	0.00489	CbGpPWpGaD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—KRAS—sarcoma	0.000629	0.00486	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—FUS—sarcoma	0.000623	0.00481	CbGpPWpGaD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—MYC—sarcoma	0.000621	0.00479	CbGpPWpGaD
Etonogestrel—Eye disorder—Epirubicin—sarcoma	0.00062	0.00131	CcSEcCtD
Etonogestrel—Hypersensitivity—Etoposide—sarcoma	0.00062	0.00131	CcSEcCtD
Etonogestrel—Haemoglobin—Doxorubicin—sarcoma	0.000617	0.0013	CcSEcCtD
Etonogestrel—Nausea—Vincristine—sarcoma	0.000617	0.0013	CcSEcCtD
Etonogestrel—Rhinitis—Doxorubicin—sarcoma	0.000616	0.0013	CcSEcCtD
Etonogestrel—Haemorrhage—Doxorubicin—sarcoma	0.000614	0.0013	CcSEcCtD
Etonogestrel—Hypoaesthesia—Doxorubicin—sarcoma	0.000611	0.00129	CcSEcCtD
Etonogestrel—Pharyngitis—Doxorubicin—sarcoma	0.000609	0.00129	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—EGFR—sarcoma	0.000607	0.00469	CbGpPWpGaD
Etonogestrel—Urinary tract disorder—Doxorubicin—sarcoma	0.000606	0.00128	CcSEcCtD
Etonogestrel—Asthenia—Etoposide—sarcoma	0.000603	0.00128	CcSEcCtD
Etonogestrel—Connective tissue disorder—Doxorubicin—sarcoma	0.000603	0.00128	CcSEcCtD
Etonogestrel—Angiopathy—Epirubicin—sarcoma	0.000602	0.00127	CcSEcCtD
Etonogestrel—Urethral disorder—Doxorubicin—sarcoma	0.000602	0.00127	CcSEcCtD
Etonogestrel—Nausea—Mitoxantrone—sarcoma	0.000601	0.00127	CcSEcCtD
Etonogestrel—Immune system disorder—Epirubicin—sarcoma	0.000599	0.00127	CcSEcCtD
Etonogestrel—Pruritus—Etoposide—sarcoma	0.000595	0.00126	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—sarcoma	0.000594	0.00459	CbGpPWpGaD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—JUN—sarcoma	0.000593	0.00458	CbGpPWpGaD
Etonogestrel—Visual impairment—Doxorubicin—sarcoma	0.000592	0.00125	CcSEcCtD
Etonogestrel—Alopecia—Epirubicin—sarcoma	0.000586	0.00124	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—MDM2—sarcoma	0.000582	0.00449	CbGpPWpGaD
Etonogestrel—Mental disorder—Epirubicin—sarcoma	0.000581	0.00123	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—IL2—sarcoma	0.00058	0.00448	CbGpPWpGaD
Etonogestrel—Erythema—Epirubicin—sarcoma	0.000578	0.00122	CcSEcCtD
Etonogestrel—Malnutrition—Epirubicin—sarcoma	0.000578	0.00122	CcSEcCtD
Etonogestrel—Diarrhoea—Etoposide—sarcoma	0.000575	0.00122	CcSEcCtD
Etonogestrel—Eye disorder—Doxorubicin—sarcoma	0.000574	0.00121	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—KRAS—sarcoma	0.000573	0.00443	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—FOXO1—sarcoma	0.000572	0.00442	CbGpPWpGaD
Etonogestrel—Flatulence—Epirubicin—sarcoma	0.000569	0.0012	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—FOXO1—sarcoma	0.000569	0.00439	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—PDGFRB—sarcoma	0.000568	0.00439	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—IL2—sarcoma	0.000567	0.00438	CbGpPWpGaD
Etonogestrel—Tension—Epirubicin—sarcoma	0.000567	0.0012	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—CCND1—sarcoma	0.000566	0.00437	CbGpPWpGaD
Etonogestrel—ESR1—Regulation of Telomerase—JUN—sarcoma	0.000565	0.00436	CbGpPWpGaD
Etonogestrel—Nervousness—Epirubicin—sarcoma	0.000561	0.00119	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—PDGFRA—sarcoma	0.000559	0.00432	CbGpPWpGaD
Etonogestrel—Back pain—Epirubicin—sarcoma	0.000559	0.00118	CcSEcCtD
Etonogestrel—Angiopathy—Doxorubicin—sarcoma	0.000557	0.00118	CcSEcCtD
Etonogestrel—Dizziness—Etoposide—sarcoma	0.000556	0.00118	CcSEcCtD
Etonogestrel—Muscle spasms—Epirubicin—sarcoma	0.000555	0.00117	CcSEcCtD
Etonogestrel—Immune system disorder—Doxorubicin—sarcoma	0.000555	0.00117	CcSEcCtD
Etonogestrel—ESR1—AP-1 transcription factor network—CCND1—sarcoma	0.000553	0.00427	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—JUN—sarcoma	0.000552	0.00426	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—CTNNB1—sarcoma	0.000548	0.00423	CbGpPWpGaD
Etonogestrel—Alopecia—Doxorubicin—sarcoma	0.000543	0.00115	CcSEcCtD
Etonogestrel—Mental disorder—Doxorubicin—sarcoma	0.000538	0.00114	CcSEcCtD
Etonogestrel—ESR1—LKB1 signaling events—TP53—sarcoma	0.000538	0.00415	CbGpPWpGaD
Etonogestrel—Ill-defined disorder—Epirubicin—sarcoma	0.000536	0.00113	CcSEcCtD
Etonogestrel—Vomiting—Etoposide—sarcoma	0.000535	0.00113	CcSEcCtD
Etonogestrel—Erythema—Doxorubicin—sarcoma	0.000534	0.00113	CcSEcCtD
Etonogestrel—Malnutrition—Doxorubicin—sarcoma	0.000534	0.00113	CcSEcCtD
Etonogestrel—ESR1—Plasma membrane estrogen receptor signaling—HRAS—sarcoma	0.000534	0.00413	CbGpPWpGaD
Etonogestrel—Rash—Etoposide—sarcoma	0.00053	0.00112	CcSEcCtD
Etonogestrel—Dermatitis—Etoposide—sarcoma	0.00053	0.00112	CcSEcCtD
Etonogestrel—Headache—Etoposide—sarcoma	0.000527	0.00111	CcSEcCtD
Etonogestrel—Flatulence—Doxorubicin—sarcoma	0.000527	0.00111	CcSEcCtD
Etonogestrel—Tension—Doxorubicin—sarcoma	0.000524	0.00111	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—CCND1—sarcoma	0.000523	0.00404	CbGpPWpGaD
Etonogestrel—Malaise—Epirubicin—sarcoma	0.000521	0.0011	CcSEcCtD
Etonogestrel—Nervousness—Doxorubicin—sarcoma	0.000519	0.0011	CcSEcCtD
Etonogestrel—Back pain—Doxorubicin—sarcoma	0.000517	0.00109	CcSEcCtD
Etonogestrel—Muscle spasms—Doxorubicin—sarcoma	0.000514	0.00109	CcSEcCtD
Etonogestrel—Cough—Epirubicin—sarcoma	0.000504	0.00107	CcSEcCtD
Etonogestrel—Convulsion—Epirubicin—sarcoma	0.0005	0.00106	CcSEcCtD
Etonogestrel—Nausea—Etoposide—sarcoma	0.0005	0.00106	CcSEcCtD
Etonogestrel—Hypertension—Epirubicin—sarcoma	0.000499	0.00105	CcSEcCtD
Etonogestrel—Ill-defined disorder—Doxorubicin—sarcoma	0.000496	0.00105	CcSEcCtD
Etonogestrel—Myalgia—Epirubicin—sarcoma	0.000492	0.00104	CcSEcCtD
Etonogestrel—Arthralgia—Epirubicin—sarcoma	0.000492	0.00104	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—sarcoma	0.000491	0.00379	CbGpPWpGaD
Etonogestrel—Anxiety—Epirubicin—sarcoma	0.00049	0.00104	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000488	0.00103	CcSEcCtD
Etonogestrel—ESR1—Aryl Hydrocarbon Receptor—HRAS—sarcoma	0.000487	0.00376	CbGpPWpGaD
Etonogestrel—Discomfort—Epirubicin—sarcoma	0.000486	0.00103	CcSEcCtD
Etonogestrel—Malaise—Doxorubicin—sarcoma	0.000482	0.00102	CcSEcCtD
Etonogestrel—ESR1—Validated nuclear estrogen receptor alpha network—MYC—sarcoma	0.000476	0.00368	CbGpPWpGaD
Etonogestrel—Anaphylactic shock—Epirubicin—sarcoma	0.000471	0.000997	CcSEcCtD
Etonogestrel—Oedema—Epirubicin—sarcoma	0.000471	0.000997	CcSEcCtD
Etonogestrel—Infection—Epirubicin—sarcoma	0.000468	0.00099	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—SRC—sarcoma	0.000468	0.00362	CbGpPWpGaD
Etonogestrel—Cough—Doxorubicin—sarcoma	0.000466	0.000986	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	0.000466	0.0036	CbGpPWpGaD
Etonogestrel—Convulsion—Doxorubicin—sarcoma	0.000463	0.000979	CcSEcCtD
Etonogestrel—Nervous system disorder—Epirubicin—sarcoma	0.000462	0.000978	CcSEcCtD
Etonogestrel—Hypertension—Doxorubicin—sarcoma	0.000461	0.000976	CcSEcCtD
Etonogestrel—Skin disorder—Epirubicin—sarcoma	0.000458	0.000968	CcSEcCtD
Etonogestrel—Arthralgia—Doxorubicin—sarcoma	0.000455	0.000962	CcSEcCtD
Etonogestrel—Myalgia—Doxorubicin—sarcoma	0.000455	0.000962	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—MYC—sarcoma	0.000454	0.00351	CbGpPWpGaD
Etonogestrel—Anxiety—Doxorubicin—sarcoma	0.000453	0.000959	CcSEcCtD
Etonogestrel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000452	0.000955	CcSEcCtD
Etonogestrel—Discomfort—Doxorubicin—sarcoma	0.00045	0.000951	CcSEcCtD
Etonogestrel—Anorexia—Epirubicin—sarcoma	0.000449	0.00095	CcSEcCtD
Etonogestrel—ESR1—Regulation of Telomerase—EGFR—sarcoma	0.000444	0.00343	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—MYC—sarcoma	0.000443	0.00343	CbGpPWpGaD
Etonogestrel—PGR—Signaling by ERBB4—NRAS—sarcoma	0.000436	0.00337	CbGpPWpGaD
Etonogestrel—Anaphylactic shock—Doxorubicin—sarcoma	0.000436	0.000922	CcSEcCtD
Etonogestrel—Oedema—Doxorubicin—sarcoma	0.000436	0.000922	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—KIT—sarcoma	0.000433	0.00335	CbGpPWpGaD
Etonogestrel—Infection—Doxorubicin—sarcoma	0.000433	0.000916	CcSEcCtD
Etonogestrel—Musculoskeletal discomfort—Epirubicin—sarcoma	0.00043	0.000908	CcSEcCtD
Etonogestrel—Nervous system disorder—Doxorubicin—sarcoma	0.000428	0.000904	CcSEcCtD
Etonogestrel—Insomnia—Epirubicin—sarcoma	0.000426	0.000902	CcSEcCtD
Etonogestrel—Skin disorder—Doxorubicin—sarcoma	0.000424	0.000896	CcSEcCtD
Etonogestrel—Paraesthesia—Epirubicin—sarcoma	0.000423	0.000895	CcSEcCtD
Etonogestrel—Somnolence—Epirubicin—sarcoma	0.000419	0.000886	CcSEcCtD
Etonogestrel—Anorexia—Doxorubicin—sarcoma	0.000416	0.000879	CcSEcCtD
Etonogestrel—Dyspepsia—Epirubicin—sarcoma	0.000415	0.000877	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CREB1—sarcoma	0.000415	0.0032	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—CREB1—sarcoma	0.000413	0.00319	CbGpPWpGaD
Etonogestrel—Decreased appetite—Epirubicin—sarcoma	0.00041	0.000866	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Epirubicin—sarcoma	0.000407	0.000861	CcSEcCtD
Etonogestrel—Fatigue—Epirubicin—sarcoma	0.000406	0.000859	CcSEcCtD
Etonogestrel—Constipation—Epirubicin—sarcoma	0.000403	0.000852	CcSEcCtD
Etonogestrel—Pain—Epirubicin—sarcoma	0.000403	0.000852	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—EGFR—sarcoma	0.000397	0.00307	CbGpPWpGaD
Etonogestrel—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000397	0.00084	CcSEcCtD
Etonogestrel—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—sarcoma	0.000395	0.00305	CbGpPWpGaD
Etonogestrel—Insomnia—Doxorubicin—sarcoma	0.000395	0.000834	CcSEcCtD
Etonogestrel—Paraesthesia—Doxorubicin—sarcoma	0.000392	0.000828	CcSEcCtD
Etonogestrel—Feeling abnormal—Epirubicin—sarcoma	0.000388	0.000821	CcSEcCtD
Etonogestrel—Somnolence—Doxorubicin—sarcoma	0.000388	0.00082	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Epirubicin—sarcoma	0.000385	0.000815	CcSEcCtD
Etonogestrel—Dyspepsia—Doxorubicin—sarcoma	0.000384	0.000812	CcSEcCtD
Etonogestrel—Decreased appetite—Doxorubicin—sarcoma	0.000379	0.000802	CcSEcCtD
Etonogestrel—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000377	0.000796	CcSEcCtD
Etonogestrel—Fatigue—Doxorubicin—sarcoma	0.000376	0.000795	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—KRAS—sarcoma	0.000375	0.0029	CbGpPWpGaD
Etonogestrel—Urticaria—Epirubicin—sarcoma	0.000375	0.000792	CcSEcCtD
Etonogestrel—Pain—Doxorubicin—sarcoma	0.000373	0.000789	CcSEcCtD
Etonogestrel—Constipation—Doxorubicin—sarcoma	0.000373	0.000789	CcSEcCtD
Etonogestrel—Abdominal pain—Epirubicin—sarcoma	0.000373	0.000788	CcSEcCtD
Etonogestrel—Body temperature increased—Epirubicin—sarcoma	0.000373	0.000788	CcSEcCtD
Etonogestrel—ESR1—Gene Expression—FUS—sarcoma	0.000365	0.00282	CbGpPWpGaD
Etonogestrel—ESR1—AP-1 transcription factor network—TP53—sarcoma	0.000364	0.00281	CbGpPWpGaD
Etonogestrel—Feeling abnormal—Doxorubicin—sarcoma	0.000359	0.00076	CcSEcCtD
Etonogestrel—Gastrointestinal pain—Doxorubicin—sarcoma	0.000357	0.000754	CcSEcCtD
Etonogestrel—Hypersensitivity—Epirubicin—sarcoma	0.000347	0.000734	CcSEcCtD
Etonogestrel—Urticaria—Doxorubicin—sarcoma	0.000347	0.000733	CcSEcCtD
Etonogestrel—Abdominal pain—Doxorubicin—sarcoma	0.000345	0.000729	CcSEcCtD
Etonogestrel—Body temperature increased—Doxorubicin—sarcoma	0.000345	0.000729	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	0.000344	0.00265	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MDM2—sarcoma	0.000343	0.00265	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—MDM2—sarcoma	0.000341	0.00264	CbGpPWpGaD
Etonogestrel—Asthenia—Epirubicin—sarcoma	0.000338	0.000715	CcSEcCtD
Etonogestrel—Pruritus—Epirubicin—sarcoma	0.000334	0.000705	CcSEcCtD
Etonogestrel—ESR1—Leptin signaling pathway—HRAS—sarcoma	0.00033	0.00255	CbGpPWpGaD
Etonogestrel—Diarrhoea—Epirubicin—sarcoma	0.000323	0.000682	CcSEcCtD
Etonogestrel—Hypersensitivity—Doxorubicin—sarcoma	0.000321	0.00068	CcSEcCtD
Etonogestrel—PGR—Signaling by ERBB4—HRAS—sarcoma	0.000319	0.00247	CbGpPWpGaD
Etonogestrel—Asthenia—Doxorubicin—sarcoma	0.000313	0.000662	CcSEcCtD
Etonogestrel—Dizziness—Epirubicin—sarcoma	0.000312	0.000659	CcSEcCtD
Etonogestrel—Pruritus—Doxorubicin—sarcoma	0.000309	0.000653	CcSEcCtD
Etonogestrel—Vomiting—Epirubicin—sarcoma	0.0003	0.000634	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CCND1—sarcoma	0.000299	0.00231	CbGpPWpGaD
Etonogestrel—Diarrhoea—Doxorubicin—sarcoma	0.000298	0.000631	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—JUN—sarcoma	0.000298	0.0023	CbGpPWpGaD
Etonogestrel—Rash—Epirubicin—sarcoma	0.000297	0.000628	CcSEcCtD
Etonogestrel—Dermatitis—Epirubicin—sarcoma	0.000297	0.000628	CcSEcCtD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—CTNNB1—sarcoma	0.000296	0.00229	CbGpPWpGaD
Etonogestrel—Headache—Epirubicin—sarcoma	0.000295	0.000624	CcSEcCtD
Etonogestrel—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	0.00029	0.00224	CbGpPWpGaD
Etonogestrel—Dizziness—Doxorubicin—sarcoma	0.000288	0.00061	CcSEcCtD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	0.000284	0.0022	CbGpPWpGaD
Etonogestrel—Nausea—Epirubicin—sarcoma	0.00028	0.000592	CcSEcCtD
Etonogestrel—Vomiting—Doxorubicin—sarcoma	0.000277	0.000586	CcSEcCtD
Etonogestrel—Rash—Doxorubicin—sarcoma	0.000275	0.000582	CcSEcCtD
Etonogestrel—Dermatitis—Doxorubicin—sarcoma	0.000275	0.000581	CcSEcCtD
Etonogestrel—Headache—Doxorubicin—sarcoma	0.000273	0.000578	CcSEcCtD
Etonogestrel—PGR—Signaling Pathways—TLE1—sarcoma	0.000267	0.00206	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—VEGFA—sarcoma	0.000261	0.00201	CbGpPWpGaD
Etonogestrel—Nausea—Doxorubicin—sarcoma	0.000259	0.000548	CcSEcCtD
Etonogestrel—ESR1—Signaling by ERBB4—NRAS—sarcoma	0.000256	0.00198	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	0.000248	0.00191	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	0.000247	0.00191	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	0.000245	0.00189	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—MYC—sarcoma	0.00024	0.00185	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—EGFR—sarcoma	0.000235	0.00181	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—EGFR—sarcoma	0.000233	0.0018	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFC—sarcoma	0.000225	0.00174	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	0.000222	0.00171	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—KRAS—sarcoma	0.000222	0.00171	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—KRAS—sarcoma	0.00022	0.0017	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	0.000216	0.00167	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	0.000199	0.00153	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Breast Cancer Pathway—TP53—sarcoma	0.000197	0.00152	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	0.000194	0.0015	CbGpPWpGaD
Etonogestrel—ESR1—Signaling by ERBB4—HRAS—sarcoma	0.000187	0.00145	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	0.000184	0.00142	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FLT1—sarcoma	0.00018	0.00139	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PLCG1—sarcoma	0.000177	0.00137	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CXCR4—sarcoma	0.00017	0.00131	CbGpPWpGaD
Etonogestrel—PGR—Generic Transcription Pathway—MYC—sarcoma	0.000168	0.0013	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—ATF1—sarcoma	0.000168	0.0013	CbGpPWpGaD
Etonogestrel—ESR1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	0.000163	0.00126	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TLE1—sarcoma	0.000157	0.00121	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFC—sarcoma	0.000132	0.00102	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IGF1R—sarcoma	0.000132	0.00102	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—FOXO1—sarcoma	0.000126	0.00097	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDGFRB—sarcoma	0.000125	0.000968	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—PDGFRA—sarcoma	0.000123	0.000953	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FLT1—sarcoma	0.000106	0.000816	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PLCG1—sarcoma	0.000104	0.000802	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KDR—sarcoma	0.000104	0.000802	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CXCR4—sarcoma	9.98e-05	0.000771	CbGpPWpGaD
Etonogestrel—ESR1—Generic Transcription Pathway—MYC—sarcoma	9.87e-05	0.000762	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—ATF1—sarcoma	9.87e-05	0.000762	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KIT—sarcoma	9.57e-05	0.000739	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CREB1—sarcoma	9.11e-05	0.000703	CbGpPWpGaD
Etonogestrel—PGR—Gene Expression—MYC—sarcoma	8.1e-05	0.000625	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IGF1R—sarcoma	7.74e-05	0.000598	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MDM2—sarcoma	7.53e-05	0.000582	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—FOXO1—sarcoma	7.37e-05	0.000569	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFRB—sarcoma	7.36e-05	0.000568	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—PDGFRA—sarcoma	7.24e-05	0.000559	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—IL2—sarcoma	6.73e-05	0.00052	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CCND1—sarcoma	6.56e-05	0.000507	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—JUN—sarcoma	6.55e-05	0.000506	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—CTNNB1—sarcoma	6.5e-05	0.000502	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KDR—sarcoma	6.09e-05	0.000471	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—SRC—sarcoma	5.87e-05	0.000454	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—VEGFA—sarcoma	5.72e-05	0.000442	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—NRAS—sarcoma	5.65e-05	0.000436	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KIT—sarcoma	5.61e-05	0.000434	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CREB1—sarcoma	5.34e-05	0.000413	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—MYC—sarcoma	5.26e-05	0.000407	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—EGFR—sarcoma	5.15e-05	0.000398	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—KRAS—sarcoma	4.86e-05	0.000376	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—ENO2—sarcoma	4.77e-05	0.000369	CbGpPWpGaD
Etonogestrel—ESR1—Gene Expression—MYC—sarcoma	4.75e-05	0.000367	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—HBA1—sarcoma	4.74e-05	0.000366	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MDM2—sarcoma	4.42e-05	0.000342	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—TP53—sarcoma	4.32e-05	0.000334	CbGpPWpGaD
Etonogestrel—PGR—Signaling Pathways—HRAS—sarcoma	4.13e-05	0.000319	CbGpPWpGaD
Etonogestrel—CYP3A4—Metabolism—PLCG1—sarcoma	4.05e-05	0.000313	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—IL2—sarcoma	3.95e-05	0.000305	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CCND1—sarcoma	3.85e-05	0.000297	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—JUN—sarcoma	3.84e-05	0.000297	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—CTNNB1—sarcoma	3.81e-05	0.000295	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—SRC—sarcoma	3.45e-05	0.000266	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—VEGFA—sarcoma	3.36e-05	0.000259	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—NRAS—sarcoma	3.32e-05	0.000256	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—MYC—sarcoma	3.09e-05	0.000239	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—EGFR—sarcoma	3.02e-05	0.000233	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—KRAS—sarcoma	2.85e-05	0.00022	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—TP53—sarcoma	2.54e-05	0.000196	CbGpPWpGaD
Etonogestrel—ESR1—Signaling Pathways—HRAS—sarcoma	2.43e-05	0.000187	CbGpPWpGaD
